Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
26.71
-0.24 (-0.89%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.77 billion as of August 26, 2026. Its market cap has increased by 274.97% in one year.
Market Cap
2.77B
Enterprise Value
2.39B
1-Year Change
274.97%
Ranking
Category
Stock Price
$26.71
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.77B, an increase of 293.70%. That is a compound annual growth rate of 25.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 2.77B | 44.15% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.94B |
| SELLAS Life Sciences Group | 2.85B |
| AtaiBeckley | 2.76B |
| Viridian Therapeutics | 2.74B |
| Generate Biomedicines | 2.62B |
| Pharvaris | 2.61B |
| Precigen | 2.61B |
| Ultragenyx Pharmaceutical | 2.60B |